Home/Shorla Oncology/Orlaith Ryan

OR

Orlaith Ryan

Co-Founder

Shorla Oncology

Therapeutic Areas

Oncology Rare Disease

Shorla Oncology Pipeline

Drug	Indication	Phase
Nelarabine Injection (larger vial)	T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL)	Approved

Leadership Team at Shorla Oncology

Sharon Cunningham

CEO & Co-Founder

View full Shorla Oncology profile